Androgen insensitivity syndrome epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 8: Line 8:


==Epidemiology and Demographic==
==Epidemiology and Demographic==
===Prevalence===
*CAIS has aprevalence of 2 per100,000 to 5 per100,000 in otherwise healthy phenotypic females who had histologically normal inguinal or abdominal testes. In netherlands, the minimal incidence was 1 per 99,000 over a ten-year period.
*PAIS is at least as common as CAIS.
*MAIS is much less frequently reported than CAIS and PAIS.
===Incidence===
===Incidence===
The incidence of complete AIS is about in 5 in 100,000. The incidence of milder degrees of androgen resistance is not known and it has been suggested by various authorities that it might be both more common or less common than CAIS. Evidence suggests many cases of unexplained male infertility may be due to the mildest forms of androgen resistance.
The incidence of complete AIS is about in 5 in 100,000. The incidence of milder degrees of androgen resistance is not known and it has been suggested by various authorities that it might be both more common or less common than CAIS. Evidence suggests many cases of unexplained male infertility may be due to the mildest forms of androgen resistance.
===Case Fatality Rate===


==References==
==References==

Revision as of 13:01, 6 July 2017

Androgen insensitivity syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Androgen insensitivity syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Androgen insensitivity syndrome epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Androgen insensitivity syndrome epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Androgen insensitivity syndrome epidemiology and demographics

CDC on Androgen insensitivity syndrome epidemiology and demographics

Androgen insensitivity syndrome epidemiology and demographics in the news

Blogs on Androgen insensitivity syndrome epidemiology and demographics

Directions to Hospitals Treating Androgen insensitivity syndrome

Risk calculators and risk factors for Androgen insensitivity syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Epidemiology and Demographic

Prevalence

  • CAIS has aprevalence of 2 per100,000 to 5 per100,000 in otherwise healthy phenotypic females who had histologically normal inguinal or abdominal testes. In netherlands, the minimal incidence was 1 per 99,000 over a ten-year period.
  • PAIS is at least as common as CAIS.
  • MAIS is much less frequently reported than CAIS and PAIS.


Incidence

The incidence of complete AIS is about in 5 in 100,000. The incidence of milder degrees of androgen resistance is not known and it has been suggested by various authorities that it might be both more common or less common than CAIS. Evidence suggests many cases of unexplained male infertility may be due to the mildest forms of androgen resistance.


Case Fatality Rate

References

Template:WH Template:WS